Unipharm Ltd. v.
Sanofi S.A.
A Landmark Case in Patent Law, Competition and Unjust Enrichment
The litigation began in the Central District Court as Unipharm Ltd. v. Sanofi S.A. and continued through the Supreme Court appeal and the Further Hearing.
From the District Court to a Further Hearing.
The litigation progressed from the District Court to the Supreme Court and then to a Further Hearing before an expanded five-Justice panel. The Further Hearing judgment was issued on 26 December 2023 by a 4–1 majority.
The page presents the matter through that procedural sequence and the two principal appellate references: CA 2167/16 and FH 5679/21.
District Court
Liability proceedings and factual findings forming the basis for the later appellate stages.
Supreme Court
CA 2167/16
Further Hearing
FH 5679/21 · Expanded five-Justice panel · judgment dated 26 December 2023.
Supreme Court
CA 2167/16.
Further Hearing
FH 5679/21.
Judgment
26 December 2023 · expanded five-Justice panel · 4–1 majority.